Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
New Drugs in Cancer Chemotherapy (Paperback, Softcover reprint of the original 1st ed. 1981)
Loot Price: R1,572
Discovery Miles 15 720
|
|
New Drugs in Cancer Chemotherapy (Paperback, Softcover reprint of the original 1st ed. 1981)
Series: Recent Results in Cancer Research, 76
Expected to ship within 10 - 15 working days
|
The Analog Potential in Cancer Chemotherapy in the United States
and Japan S. K. Carter Northern California Cancer Program, 1801
Page Mill Road, Building B, Suite 200, USA - Palo Alto, CA 94304
The bilateral collaborative program in cancer research between
Japan and the United States is one of the oldest programs of this
type. It is sponsored in the United States by the National Cancer
Institute [1], while in Japan the sponsoring organization is the
Japan Society for the Promotion of Science. Annual symposia
concerning treatment have been held and in recent years they have
been published [2, 3]. Drug development in both Japan and the
United States has evolved over the years to an increasing emphasis
on second generation compounds. This has come about as a result of
the initial successes of chemotherapy development. Many active
structures have been uncovered and the armamentarium of the medical
and pediatric oncologist has grown dramatically. The uncovering of
an active structure provides an opportunity for analog synthesis
and attempts at elucidating structure-activity relationships. It is
hoped that the therapeutic index of active structures can be
improved so as to achieve superior clinical results.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.